• HOME
  • Topics
Original Article
Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
Chung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Cheng-Ting Hsu, Po-Yao Hsu, Hung-Yin Liu, Ying-Chou Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Clin Mol Hepatol. 2021;27(1):136-143.   Published online December 3, 2020
View: 3931   Download: 155  Citations: 18
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
Clin Mol Hepatol. 2021;27(1):125-135.   Published online November 27, 2020
View: 3465   Download: 129  Citations: 2
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
Clin Mol Hepatol. 2021;27(1):110-124.   Published online December 3, 2020
View: 6474   Download: 388  Citations: 36
Old hepatitis B virus never dies: It just hides itself within the host genome
Jeong-Hoon Lee
Clin Mol Hepatol. 2021;27(1):107-109.   Published online December 23, 2020
View: 2535   Download: 107  Citations: 2
Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
Jun Won Kim, Ik Jae Lee
Clin Mol Hepatol. 2021;27(1):103-106.   Published online December 14, 2020
View: 2535   Download: 88
Elimination of hepatitis C: What would be the practical approach?
Hyung Joon Yim
Clin Mol Hepatol. 2021;27(1):97-99.   Published online December 3, 2020
View: 3423   Download: 103  Citations: 2
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
View: 2814   Download: 117  Citations: 3
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol. 2021;27(1):87-90.   Published online December 3, 2020
View: 3283   Download: 98  Citations: 8
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 3348   Download: 133
Drug-drug interactions with direct-acting antivirals — less is more
Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(1):81-82.   Published online December 3, 2020
View: 2523   Download: 94  Citation: 1
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clin Mol Hepatol. 2021;27(1):70-80.   Published online December 3, 2020
View: 8380   Download: 325  Citations: 33
Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
Clin Mol Hepatol. 2021;27(1):58-69.   Published online December 10, 2020
View: 8928   Download: 760  Citations: 25
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clin Mol Hepatol. 2021;27(1):22-43.   Published online December 10, 2020
View: 6563   Download: 384  Citations: 26
Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clin Mol Hepatol. 2021;27(1):1-21.   Published online December 3, 2020
View: 8316   Download: 606  Citations: 25
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu, Xiaohui Wang, Yingzi Yang
Clin Mol Hepatol. 2020;26(4):742-750.   Published online September 28, 2020
View: 5240   Download: 171  Citations: 28
Alcohol and hepatocarcinogenesis
Makiko Taniai
Clin Mol Hepatol. 2020;26(4):736-741.   Published online October 1, 2020
View: 4064   Download: 129  Citations: 10
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735.   Published online October 1, 2020
View: 4068   Download: 149  Citations: 23
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol. 2020;26(4):715-727.   Published online September 22, 2020
View: 5924   Download: 225  Citations: 18
Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
Clin Mol Hepatol. 2020;26(4):705-714.   Published online October 1, 2020
View: 3068   Download: 75  Citations: 5
Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell
Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong
Clin Mol Hepatol. 2020;26(4):697-704.   Published online October 1, 2020
View: 3906   Download: 121  Citations: 5
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696.   Published online September 28, 2020
View: 4151   Download: 186  Citations: 8
Roles of the complement system in alcohol-induced liver disease
Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He
Clin Mol Hepatol. 2020;26(4):677-685.   Published online October 1, 2020
View: 4614   Download: 120  Citations: 6
Liver-lung axes in alcohol-related liver disease
Gavin E. Arteel
Clin Mol Hepatol. 2020;26(4):670-676.   Published online October 1, 2020
View: 3410   Download: 91  Citations: 6
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669.   Published online September 25, 2020
View: 6162   Download: 152  Citations: 19
Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies
Seung Ha Park, Dong Joon Kim
Clin Mol Hepatol. 2020;26(4):652-661.   Published online October 1, 2020
View: 3184   Download: 81  Citations: 11
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651.   Published online October 1, 2020
View: 5893   Download: 166  Citations: 6
The lymphatic system in alcohol-associated liver disease
Reiichiro Kondo, Yasuko Iwakiri
Clin Mol Hepatol. 2020;26(4):633-638.   Published online September 21, 2020
View: 5657   Download: 125  Citation: 1

Clinical and

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail:
Copyright © The Korean Association for the Study of the Liver.         
TODAY : 1408
TOTAL : 1212573
Close layer